<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Genmab A/S

    verified_userVerify Profile
    Companies » Health Care » Health Care Equipment & Services » Biotechnology

    About Genmab A/S

    Genmab is a publicly traded, international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer. Founded in 1999, the company has two approved antibodies, a broad clinical and pre-clinical product pipeline and three proprietary next generation antibody technologies. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $1,100,000,000
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Jan G. J. van de Winkel, Ph.D.
    • FOUNDED
      1999
    • EMPLOYEES
      251-500
    • SECTOR
      Health Care Equipment & Services
    • SUBSECTOR
      Biotechnology

    Company Tags

    No articles found.

    Alseres Pharmaceuticals

    Alseres Pharmaceuticals

    Alseres Pharmaceuticals, Inc. is focused on the development of diagnostic and ther...

    Alseres Pharmaceuticals, Inc. is focused on the...

    Amount Raised:    $5,900,000
    Fundraising Status:    VT
    Filing Type:    PU
    MYOS RENS Technology Inc.

    MYOS RENS Technology Inc.

    MYOS RENS Technology, Inc. (NASDAQ: MYOS), a company based in Cedar Knolls, NJ was...

    MYOS RENS Technology, Inc. (NASDAQ: MYOS), a co...

    Filing Type:    PU
    Natera, Inc.

    Natera, Inc.

    Natera is a rapidly-growing diagnostics company with proprietary bioinformatics an...

    Natera is a rapidly-growing diagnostics company...

    Filing Type:    PU
    Akibah Health Corporation

    Akibah Health Corporation

    GluCase is an all-in-one diabetes management system that seamlessly integrates a g...

    GluCase is an all-in-one diabetes management sy...

    Amount Raised:    $38,481.00
    Fundraising Status:    EC
    Filing Type:    CF
    Anthera Pharmaceuticals, Inc.

    Anthera Pharmaceuticals, Inc.

    Anthera Pharmaceuticals, Inc., a development stage biopharmaceutical company, focu...

    Anthera Pharmaceuticals, Inc., a development st...

    Amount Raised:    $65,500,000
    Fundraising Status:    VT
    Filing Type:    PU
    NanoVibronix, Inc.

    NanoVibronix, Inc.

    NanoVibronix Inc. is a medical device company that is focused on creating medical ...

    NanoVibronix Inc. is a medical device company t...

    Filing Type:    PU
    IGM Biosciences, Inc.

    IGM Biosciences, Inc.

    Headquartered in Mountain View, California, IGM Biosciences is a biotechnology com...

    Headquartered in Mountain View, California, IGM...

    Filing Type:    PU
    Immunomedics, Inc.

    Immunomedics, Inc.

    Immunomedics is a clinical-stage biopharmaceutical company developing monoclonal a...

    Immunomedics is a clinical-stage biopharmaceuti...

    Filing Type:    PU
    Jounce Therapeutics, Inc.

    Jounce Therapeutics, Inc.

    Jounce Therapeutics is a clinical stage immunotherapy company dedicated to transfo...

    Jounce Therapeutics is a clinical stage immunot...

    Filing Type:    PU
    DermTech, Inc.

    DermTech, Inc.

    DermTech is the global leader in molecular dermatology, bringing precision medicin...

    DermTech is the global leader in molecular derm...

    Filing Type:    PU
    Immutep Limited

    Immutep Limited

    We are a biotechnology company developing novel immunotherapy treatments for cance...

    We are a biotechnology company developing novel...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.